Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chenmin, Ye"'
Autor:
Chengyang Yu, Zhiqiang Zheng, Yongdong Yi, Weijian Sun, Wenqian Wang, Guojun Xia, Chunyan Hua, Fuyang Tu, Chenmin Ye, Leibin Shen, Canjin Chen
Publikováno v:
OncoTargets and Therapy. 12:2259-2269
Chenmin Ye,1,2,* Wenqian Wang,3,* Guojun Xia,1,2,* Chengyang Yu,1,2 Yongdong Yi,1,2 Chunyan Hua,4 Fuyang Tu,1,2 Leibin Shen,1,2 Canjin Chen,1,2 Weijian Sun,1 Zhiqiang Zheng1 1Department of Gastrointestinal Surgery, The Second Affiliated Hospital and
Autor:
Chenmin, Ye, Wenqian, Wang, Guojun, Xia, Chengyang, Yu, Yongdong, Yi, Chunyan, Hua, Fuyang, Tu, Leibin, Shen, Canjin, Chen, Weijian, Sun, Zhiqiang, Zheng
Publikováno v:
OncoTargets and therapy
Purpose Gastric carcinoma is the second most frequently diagnosed cancer and leading cause of cancer death in China. As a new generation of cancer therapeutic drug, CL-6, a curcumin derivative, shows better bioavailability than curcumin, which has sh
Autor:
Jun Wang, Yongdong Yi, Chengyang Yu, Rongrong Wang, Zhiqiang Zheng, Fuyang Tu, Guojun Xia, Leibin Shen, Jingxuan Xu, Chenmin Ye
Publikováno v:
Drug testing and analysis. 11(4)
The aim of this study was to investigate the possible effect of orally administered isavuconazole, ketoconazole, or voriconazole on the pharmacokinetics of methadone in rats. Twenty Sprague-Dawley (SD) rats were divided randomly into four groups: Gro
Autor:
Chunya Hua, Zhi-qiang Zheng, Bin He, Canjin Chen, Yaxin Zhao, Chenmin Ye, Wenqian Wang, Xiaoying Xu, Guojun Xia, Weijian Sun, Xian Shen, Yaojun Yu, Yongdong Yi, Beng Yang, Fuyang Tu, Chengyang Yu, Liyi Li
Publikováno v:
Mol Ther
Histone deacetylase inhibitors (HDACis) are the recommended treatment for many solid tumors; however, resistance is a major clinical obstacle for their efficacy. High levels of the transcription factor nuclear factor erythroid 2 like-2 (Nrf2) in canc
Autor:
Chenmin Ye, Guojun Xia, Yongdong Yi, Chunyan Hua, Chengyang Yu, Wenqian Wang, Sheng Gao, Fuyang Tu, Leibin Shen
Publikováno v:
Autoimmunity reviews. 18(1)
Triggering receptor expressed on myeloid cells-1 (TREM-1) engagement can directly trigger inflammation or amplify an inflammatory response by synergizing with TLRs or NLRs. Autoimmune diseases are a family of chronic systemic inflammatory disorders.